Article
Androgen signaling and its interactions with other signaling pathways in prostate cancer
15 Nov 2007
Abstract excerpt
Prostate cancer is the most frequently diagnosed non-skin cancer and the third leading cause of cancer mortality in men. In the initial stages, prostate cancer is dependent on androgens for growth, which is the basis for androgen ablation therapy. However, in most cases, prostate cancer progresses to a hormone refractory phenotype for which there is no effective therapy available at present. The androgen receptor...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
